Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Red is a color of Christmas and Elite. ??
You often see public companies buy back shares to offset the dilution that is caused by paying management, BOD, etc each year. Has that caused any dilution over the years? Why yes, yes it has. Plus, the track record of return on R&D is quite questionable. There’s plenty of reason shareholders should be worked up due to lack of visibility and communication about future investments.
Well, profit on candles would be higher than 17%.
The CEO did. He knows better than all the made up hype here.
CEO already said Covid wasn’t in the cards. Not sure why they wouldn’t be believed.
Well, today Elite is near .03/share USD is worth over 4 Jamaican dollars, 4 Liberian dollars or even 6 whole Guyanaese dollars. Wow!
Perhaps Elite management was astute with global currencies all along in speaking about attaining dollarland. We’ve already reached it in several parts of the globe.
Friendly reminder that these are ANDAs, not NDAs. Significant difference.
Don’t forget to look at their pipeline. How many drugs do they have in phase 3, phase 2, etc. Love the visibility here from the leadership team.
I believe Elite has previously said that they don’t have a partner and are not looking for one for Codeine/acet.
Agreed, no recent previous mention of it. Good to see.
Just an FYI that 3 cents is for one share, not the entire company.
Completely disagree.
He wouldn’t gain more shares with a lower price? Soon as possible isn’t as soon as option expiration where options become worthless.
Options expire. Shares don’t. Give that some thought.
Elite continues to dilute today through 50% stock comp to CEO vs using options as executive compensation to incentivize that stock price moves in upwards direction for all shareholders.
Reality is that we’re far closer to a record low.
Don’t need an algorithm. No interest on buy side as pipeline hasn’t moved in almost 2 years now.
Does the CEO benefit in any way with a lower share price? Yes, yes he does.
Nasrat said the stock wouldn’t go to 2 cents. Does 2.3 cents count?
Retail bolder is bailing. Sick of lack of share price appreciation after 8 years. Clear as day.
Tax loss selling. More to take place over next few weeks.
The stock market is forward looking. A company can have a stellar financial quarter, but the stock price drop on tighter margins, competitive pressure, etc. The market is saying that there isn’t a strong liking towards giving Elite favorable forward looking multiple based on future potential.
Elite is currently not far from being a one trick pony with Adderall holding up the fort. Majority of revenue coming from one sales distributor. Lots of risk and no pipeline movement for almost 2 years now. If that’s not maintaining status quo, I’m not sure what is. Adderall ER sales are poor at best. We have no idea what else the company is working on and likelihood of execution. Could be several drugs akin to Loxapine for all we know.
Elite’s history of investments haven’t gone well. Several ANDAs sold off for fraction of investment andafter pumping millions into SequestOx the tech has failed. I see very few reasons why a larger multiple should be given to Elite due to their history, current risk profile and future revenue and profitability outlook. Using an industry average forward multiple simply can’t be justified. Stock price will continue to feel pressure as it has for several years due to lack of execution. Stock price has it all built in. No manipulation, but some want you to buy into that story.
Elite holds the same view
Solid day. Solid red day. Company hasn’t doesn’t have any news since Adderall XR approval? Coming up on 2nd year anniversary soon…
Tooting of horns when LePree becomes VP, but silence when he leaves. ??
The company is a revolving door for critical employees and distributors. Funny how the only relationship that has been sustained over the years is with Mikah, a company that was initially communicated that it would be shut down upon becoming CEO. Wonder why?
I completely agree, but generics aren’t novel new drugs. I would have expected a BE or two many months ago.
Nasrat give Elite a discount? Not sure that’s likely given the original sale of Mikah drugs to Elite. Overvalued and Elite overpaid at the expense of a significant amount of dilution that hasn’t paid off to this day.
Agreed
They simply amended the agreement for two years instead of one. Now they are stuck with a partner that can’t sell Adderall XR for even longer.
Highly doubtful they would break the contract. Lannett could simply not renew it and give the appropriate notification to Elite. If Lannett chooses to end the contract Elite would go sub 2 cents quickly. Transitioning to a new partner doesn’t take place overnight.
Epic, Dr Reddy, Sungen, Epic v2.0, Prasco, Lannett…solid list right there of partnerships over the years.
Until Lannett gets their Adderall IR ANDA as well.
The end of the 3-year initial agreement comes to a close in March. That’s a much bigger issue. They could extend for 1-year periods.
Is this the reason why XR never went far? Has Lannett had a different plan all along? One more partnership getting flushed ??
Which is why Elite is in such a hurry to diversify in case anything happens to Adderall as Nasrat has previously stated…
Troxyca was FDA approved in 2016. The 3.5 year exclusivity came and went long ago.
Tax loss season continues…
Stock price has been tanking for years, not months. Institutional ownership is relatively nonexistent. Management has shot themselves in the foot with the LPC floor price each and every time.
And move to Florida where they have a nice office?
Contacted doesn’t mean there is any remote interest.